INTS vs MMC
Intensity Therapeutics, Inc. Common stock (INTS) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
INTS currently screens at market cap $7.7M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the INTS and MMC stock pages for the full models.
Not investment advice.